PT689534E - Derivados amida como ligandos de 5-ht1a - Google Patents
Derivados amida como ligandos de 5-ht1aInfo
- Publication number
- PT689534E PT689534E PT94908456T PT94908456T PT689534E PT 689534 E PT689534 E PT 689534E PT 94908456 T PT94908456 T PT 94908456T PT 94908456 T PT94908456 T PT 94908456T PT 689534 E PT689534 E PT 689534E
- Authority
- PT
- Portugal
- Prior art keywords
- pct
- date
- amida
- derived
- sec
- Prior art date
Links
- 102100022738 5-hydroxytryptamine receptor 1A Human genes 0.000 title abstract 2
- 101710138638 5-hydroxytryptamine receptor 1A Proteins 0.000 title abstract 2
- 239000003446 ligand Substances 0.000 title 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 239000002249 anxiolytic agent Substances 0.000 abstract 1
- 230000000949 anxiolytic effect Effects 0.000 abstract 1
- 229940005530 anxiolytics Drugs 0.000 abstract 1
- 239000011230 binding agent Substances 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000002950 monocyclic group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939305672A GB9305672D0 (en) | 1993-03-19 | 1993-03-19 | Amide derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
PT689534E true PT689534E (pt) | 2003-01-31 |
Family
ID=10732342
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT94908456T PT689534E (pt) | 1993-03-19 | 1994-03-09 | Derivados amida como ligandos de 5-ht1a |
Country Status (13)
Country | Link |
---|---|
US (1) | US5629323A (pt) |
EP (1) | EP0689534B1 (pt) |
JP (1) | JPH08507779A (pt) |
AT (1) | ATE225335T1 (pt) |
AU (1) | AU6149094A (pt) |
DE (1) | DE69431471T2 (pt) |
DK (1) | DK0689534T3 (pt) |
ES (1) | ES2181711T3 (pt) |
GB (1) | GB9305672D0 (pt) |
PH (1) | PH31589A (pt) |
PT (1) | PT689534E (pt) |
WO (1) | WO1994021611A1 (pt) |
ZA (1) | ZA941739B (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5541179A (en) * | 1995-05-02 | 1996-07-30 | American Home Products Corporation | Tropon-2-one piperazine carboxamides as serotonergic agents |
US5990114A (en) * | 1996-02-28 | 1999-11-23 | Recordati, S.A., Chemical And Pharmaceutical Company | Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence |
US6906069B1 (en) | 1999-01-08 | 2005-06-14 | Amgen Inc. | LXR modulators |
EP1035115B1 (en) | 1999-02-24 | 2004-09-29 | F. Hoffmann-La Roche Ag | 4-Phenylpyridine derivatives and their use as NK-1 receptor antagonists |
AU2000235960A1 (en) * | 2000-02-14 | 2001-08-27 | Tularik, Inc. | Lxr modulators |
US6673543B2 (en) | 2000-04-05 | 2004-01-06 | Tularik, Inc. | Solid phase synthesis of LXR ligands |
EP1476425A4 (en) | 2002-01-30 | 2010-05-05 | Amgen Inc | Heterocyclic Aryl Sulphonamidocyclic Compounds |
TWI280239B (en) | 2003-07-15 | 2007-05-01 | Hoffmann La Roche | Process for preparation of pyridine derivatives |
EP1928427B1 (en) | 2005-09-23 | 2009-12-30 | F.Hoffmann-La Roche Ag | Novel dosage formulation |
US10316025B2 (en) | 2015-06-03 | 2019-06-11 | Sunshine Lake Pharma Co., Ltd. | Substituted piperazine compounds and methods of use and use thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1244418A (en) * | 1984-07-30 | 1988-11-08 | Marcel Hibert | Glutarimide antianxiety and antihypertensive agents |
EP0367888A1 (en) * | 1988-11-08 | 1990-05-16 | ISTITUTO LUSO FARMACO D'ITALIA S.p.A. | 2,2-Disubstituted 2,3-dihydro-1,4-benzodioxin derivatives having hypotensive activity |
GB9021535D0 (en) * | 1990-10-03 | 1990-11-14 | Wyeth John & Brother Ltd | Piperazine derivatives |
MX9201991A (es) * | 1991-05-02 | 1992-11-01 | Jonh Wyeth & Brother Limited | Derivados de piperazina y procedimiento para su preparacion. |
-
1993
- 1993-03-19 GB GB939305672A patent/GB9305672D0/en active Pending
-
1994
- 1994-03-09 JP JP6520749A patent/JPH08507779A/ja not_active Withdrawn
- 1994-03-09 AU AU61490/94A patent/AU6149094A/en not_active Abandoned
- 1994-03-09 US US08/446,651 patent/US5629323A/en not_active Expired - Lifetime
- 1994-03-09 AT AT94908456T patent/ATE225335T1/de not_active IP Right Cessation
- 1994-03-09 WO PCT/GB1994/000455 patent/WO1994021611A1/en active IP Right Grant
- 1994-03-09 DK DK94908456T patent/DK0689534T3/da active
- 1994-03-09 DE DE69431471T patent/DE69431471T2/de not_active Expired - Fee Related
- 1994-03-09 EP EP94908456A patent/EP0689534B1/en not_active Expired - Lifetime
- 1994-03-09 ES ES94908456T patent/ES2181711T3/es not_active Expired - Lifetime
- 1994-03-09 PT PT94908456T patent/PT689534E/pt unknown
- 1994-03-11 ZA ZA941739A patent/ZA941739B/xx unknown
- 1994-03-17 PH PH47940A patent/PH31589A/en unknown
Also Published As
Publication number | Publication date |
---|---|
DE69431471D1 (de) | 2002-11-07 |
ES2181711T3 (es) | 2003-03-01 |
PH31589A (en) | 1998-11-03 |
EP0689534B1 (en) | 2002-10-02 |
WO1994021611A1 (en) | 1994-09-29 |
AU6149094A (en) | 1994-10-11 |
US5629323A (en) | 1997-05-13 |
DE69431471T2 (de) | 2003-07-10 |
JPH08507779A (ja) | 1996-08-20 |
ZA941739B (en) | 1995-09-11 |
ATE225335T1 (de) | 2002-10-15 |
GB9305672D0 (en) | 1993-05-05 |
EP0689534A1 (en) | 1996-01-03 |
DK0689534T3 (da) | 2003-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9300194D0 (en) | Piperazine derivatives | |
MY109337A (en) | Phenoxyl-and phenoxyalkyl-piperidines as antiviral agents | |
PT689534E (pt) | Derivados amida como ligandos de 5-ht1a | |
ZA945007B (en) | Heterocyclic derivatives | |
TW281673B (pt) | ||
DE59304311D1 (de) | N-substituierte 3-azabicyclo[3.2.0]heptan-derivate als neuroleptika | |
DE69616357D1 (de) | Benzocycloalken-verbindungen mit bindungsaffinität an den melatonin-rezeptor, ihre herstellung und verwendung | |
ATE278676T1 (de) | Imdazol-derivate, deren herstellung und deren verwendung als s-adenosylmethionin decarboxylase (=samdc) inhibitoren | |
NZ291855A (en) | Bridged azabicyclo-piperazin-1-yl-2-phenyl-butan-1-one derivatives as 5-ht1a antagonists | |
TW282458B (pt) |